Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.
Status:
Recruiting
Trial end date:
2023-09-22
Target enrollment:
Participant gender:
Summary
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women
with ER Positive, HER2 Negative Advanced Breast Cancer (SERENA-1)